DVL.AX
dorsaVi Ltd
Price:  
0.01 
AUD
Volume:  
63,881.00
Australia | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DVL.AX WACC - Weighted Average Cost of Capital

The WACC of dorsaVi Ltd (DVL.AX) is 7.3%.

The Cost of Equity of dorsaVi Ltd (DVL.AX) is 8.20%.
The Cost of Debt of dorsaVi Ltd (DVL.AX) is 4.60%.

Range Selected
Cost of equity 6.30% - 10.10% 8.20%
Tax rate 18.50% - 23.40% 20.95%
Cost of debt 4.60% - 4.60% 4.60%
WACC 5.8% - 8.8% 7.3%
WACC

DVL.AX WACC calculation

Category Low High
Long-term bond rate 4.0% 4.5%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.44 0.83
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.30% 10.10%
Tax rate 18.50% 23.40%
Debt/Equity ratio 0.23 0.23
Cost of debt 4.60% 4.60%
After-tax WACC 5.8% 8.8%
Selected WACC 7.3%

DVL.AX's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for DVL.AX:

cost_of_equity (8.20%) = risk_free_rate (4.25%) + equity_risk_premium (5.60%) * adjusted_beta (0.44) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.